BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lou H, Cao X. Antibody variable region engineering for improving cancer immunotherapy. Cancer Commun (Lond) 2022. [PMID: 35822503 DOI: 10.1002/cac2.12330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mahmood T, Shahbaz A, Hussain N, Ali R, Bashir H, Rizwan K. Recent advancements in fusion protein technologies in oncotherapy: A review. Int J Biol Macromol 2023;230:123161. [PMID: 36610574 DOI: 10.1016/j.ijbiomac.2023.123161] [Reference Citation Analysis]
2 Kalim M, Ali H, Rehman AU, Lu Y, Zhan J. Bioengineering and computational analysis of programmed cell death ligand-1 monoclonal antibody. Front Immunol 2022;13:1012499. [DOI: 10.3389/fimmu.2022.1012499] [Reference Citation Analysis]